Simplifying Sustained Release Oral Dosage Forms with High Viscosity HPMC (Hypromellose)

Why developing sustained release formulations?

Sustained release (SR) pharmaceutical formulations are built to deliver a drug at a steady, regulated pace across a prolonged timeframe. Whereas conventional products release the active ingredient quickly and typically call for repeated dosing, SR products are designed to hold therapeutic plasma levels while requiring fewer doses. The outcome is better patient adherence, greater therapeutic effectiveness, and fewer side effects tied to the peaks and troughs of drug concentration in the blood.

SR formulations are especially valuable for medicines used in the long-term treatment of chronic diseases and for those with a short half-life. Because they release the drug at a consistent rate, they keep patients at ideal medication levels across the day and reduce the swings that might otherwise produce weak therapeutic responses or unwanted reactions.

The engineering behind SR systems takes many forms, but the most widespread approaches embed the drug within a matrix or apply a coating of materials that govern how it is released. Such formulations frequently depend on polymers like Hydroxypropyl methylcellulose (HPMC), which can build gels or comparable structures that slow the drug’s release over time [1].

Principles of Sustained Release with HPMC

HPMC is a hydrophilic, non-ionic cellulose ether that produces a gel layer when it meets water, and it manages drug release through the following:

• Hydration & Gel Formation: As the tablet meets aqueous fluids, the HPMC takes up water and swells, building a viscous gel layer around the tablet core.
• Diffusion-Controlled Release: The drug moves through the gel layer at a speed set by its solubility together with the gel’s viscosity and the polymer concentration.

Erosion-Controlled Release: The outermost gel layer wears away over time, freeing the drug in a controlled fashion.

Selection of Hypromellose grades and conditions for hydrophilic matrix system

Key control parameters for hydrophilic matrix formulations based on Hypromellose:

Drug solubility

A drug’s solubility sets the dominant way it leaves a hydrophilic matrix. When a drug is highly soluble, its release is chiefly driven by diffusion through the hydrated Hypromellose gel layer. Poorly soluble drugs, on the other hand, depend more heavily on erosion of the gel matrix, since their low solubility limits how well they can diffuse.

Hypromellose viscosity

The viscosity grade of Hypromellose (HPMC) shapes the gel layer that forms during hydration. Grades with higher viscosity yield thicker, more viscous gels that hold back water ingress and drug diffusion, giving a slower release. Grades with lower viscosity encourage quicker dissolution.

Hypromellose content

How much Hypromellose a formulation contains is central to regulating drug release. A greater HPMC load produces a thicker gel layer on hydration, which restrains drug diffusion and stretches out release. A smaller load, by contrast, forms a thinner barrier and permits faster release. Just as important, the Hypromellose must be spread evenly through the tablet matrix so that the gel layer forms uniformly. That evenness supports consistent drug release and guards against localized differences that might cause dose dumping, incomplete release, or an initial burst effect.

Hypromellose substitution types

Differences in Hypromellose’s chemical substitution (for instance, its methoxy and hydroxypropyl groups) shape how it hydrates, how strong the resulting gel is, and how the overall matrix is structured. These distinctions change how fast water works into the matrix and therefore the drug release profile. Hydration time matters especially here: substitution types that hydrate faster (HPMC type 2208) build gel layers sooner and give immediate control over release, while slower-hydrating types (HPMC type 2910) can hold back gel formation, which may lead to a faster initial dissolution profile, a burst release, or inconsistent dissolution.

How to use Hypromellose for hydrophilic matrix system

Hydrophilic matrix tablets can be made by either direct compression (DC) or wet granulation (WG).

Direct compression

METOLOSE® and TYLOPUR® 90SH-SR offer enough flowability and compressibility to act as an ideal hydrophilic matrix component in direct compression. As long as the other ingredients in the formulation do not markedly reduce these properties, the formulation can be processed by direct compression.

Wet granulation

When the API’s flowability is the limiting factor (particularly in high-load formulations), matrix tablets can instead be produced with a wet granulation step. The granulation may be carried out with a solvent/water blend (for example, 80:20 % ethanol) in standard equipment such as a high shear mixer.

Pros and Cons of High Viscosity HPMC in SR Formulations

Advantages

Widely accepted: FDA-approved and holds GRAS (Generally Recognized as Safe) status.

Flexible release profiles: tunable by changing the HPMC viscosity grade and concentration.

Simple formulation: needs only the API, HPMC, a lubricant, and a filler.

Direct Compression (DC): HPMC’s good flowability and compactibility make direct compression feasible.

Wet granulation (WG): solvent-based wet granulation is available for more demanding formulations.

High API load: capable of accommodating high drug loadings.

Compatibility: its non-ionic character lets it work with a wide range of APIs (for example, metformin, pseudoephedrine, theophylline).

Cost-effective: less expensive than certain synthetic polymers.

Non-toxic: safe for oral administration.

Disadvantages

Sensitivity to some excipients: certain fillers can affect the final dissolution rate of the API in HPMC hydrophilic matrix systems.

Conclusion

Hypromellose (HPMC) continues to be a trusted and versatile polymer for sustained-release (SR) oral formulations, owing to its reliable gel-forming behaviour, favourable safety profile, and flexibility across many types of drugs. High-viscosity grades, like those found in metformin SR tablets, effectively regulate drug release through matrix hydration and the formation of a gel barrier, which improves therapeutic efficacy while easing gastrointestinal side effects. Designing SR formulations successfully depends on sensibly choosing the HPMC viscosity grade and carefully optimizing the polymer concentration to reach the intended release kinetics and secure batch-to-batch consistency.

Continue reading the original article here 

Source/ References:

Primary source: Setylose Blog, “Easy Sustained Release Drug Delivery Formulations Using High Viscosity HPMC (Hypromellose) in Oral Dosage Forms.” Available at: https://www.setylose.com/en/blog/easy-sustained-release-drug-delivery-formulations-using-high-viscosity-hpmc-hypromellose-in-oral-dosage-forms

[1] Hydrophilic matrix tablets for oral controlled release; Timmins, P., Pygall, S.R., Melia, C.D. (Eds.). 2014, IX, 323 p. 102 illus., 37 illus in color., Hardcover, ISBN: 978-1-4939-1518-7.

[2] Bose S, Kaur A, Sharma SK. A review on advances of sustained release drug delivery system. Int Res J Pharm 2013; 4(6): 1-5.

[3] Handbook of Pharmaceutical Excipients (Rowe et al.)

Interested in more information or a sample from Shin-Etsu excipients?